Resource Library

Search All Resources

  • Clear All
Sample CPA (BOP)

Type: Download  

Audience: Clinical  

Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams  

Keywords: #bop  #cpa  #dm  #hcv  #hepc  #mat  

Sample Collaborative Practice Agreement (CPA) for Pharmacy Delivered Patient Care Services, including Diabetes, Hepatitis C, and Medication-Assisted Treatment within the Federal Bureau of Prisons (BOP)

Date added: 10/29/21

Detection of Impaired Cognition Which has Impact on Function (Dementia): Earlier is Better! | October 28, 2021

Type: Past Presentation  

Audience: Clinical  Community  

Keywords: #alzheimer's  #cognition  #dementia  #detection  #function  #impaired  

Early detection of impaired cognition can slow progression and improve function in Alzheimer’s disease and other kinds of progressive dementia, help persons living with dementia and their family to prepare and adapt, and can help find and treat conditions that ...

Date added: 10/28/21

Fentanyl’s Rising Presence in Oregon | October 27, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #fentanyl  

In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed to risks of fentanyl, and highlight how we may better ...

Date added: 10/27/21

HIV Care and Sexual Health Assessment for American Indian and Alaska Native Patients (UIHI)

Explore best practices in inclusive sexual health assessment and HIV care. This course is made for health professionals who provide medical care to American Indian and Alaska Native patients. All modules are available free of charge and are eligible to provide ...

Date added: 10/27/21

Managing Latent TB for the I/T/U Provider | October 21, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Infectious Disease  

Keywords: #covid  #covid-19  #id  #infectious disease  #latent  #tb  #tuberculosis  

In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on emerging COVID-19 topics. Then, Dr. Marcos Burgos, associate professor and Medical Director of the Tuberculosis Program for the New ...

Date added: 10/21/21

Kratom | October 7, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #kratom  

In this presentation, Dr. Jonathan Robbins discusses the substance Kratom, outlines the dangers of Kratom Use Disorder, and addresses evidence based treatment options.  

Date added: 10/20/21

Fentanyl’s Rising Presence in Oregon | October 5, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Harm Reduction  

Keywords: #fentanyl  

In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed to risks of fentanyl, and highlight how we can better ...

Date added: 10/20/21

Timing and Cognitive Screening – Big Picture | October 14, 2021

Type: Past Presentation  

Audience: Clinical  

Keywords: #cognitive screening  

Dementia, of all kinds, occurs in all communities and is a chronic disease. With the proper tools and education, it can be diagnosed and managed, for the most part, in primary care. In this presentation, Dr. Blythe Winchester discusses risk ...

Date added: 10/20/21

Harm Reduction Resources Near You

Type: Website  

Audience: Community  

Program: Harm Reduction  Infectious Disease  

Harm reduction aims to connect people who use drugs to resources and community to thrive. Whether you use drugs, or love someone who does, this page is an access point to resources that support safer drug use.

Date added: 10/20/21

Managing Symptoms During Hepatitis C Treatment (ANTHC)

Type: Handouts  

Audience: Community  

Program: Hepatitis C  Infectious Disease  

Guidance on how to manage many of the common symptoms during hepatitis C treatment.

Date added: 10/20/21